113 related articles for article (PubMed ID: 1715200)
21. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
van der Linden J; Lindvall G; Sartipy U
Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
[TBL] [Abstract][Full Text] [Related]
22. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
23. Aprotinin does not increase the risk of renal failure in cardiac surgery patients.
Furnary AP; Wu Y; Hiratzka LF; Grunkemeier GL; Page US
Circulation; 2007 Sep; 116(11 Suppl):I127-33. PubMed ID: 17846292
[TBL] [Abstract][Full Text] [Related]
24. Aprotinin: 1 year on.
Dietrich W
Curr Opin Anaesthesiol; 2009 Feb; 22(1):121-7. PubMed ID: 19295302
[TBL] [Abstract][Full Text] [Related]
25. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy.
Lu H; Du Buit C; Soria J; Touchot B; Chollet B; Commin PL; Conseiller C; Echter E; Soria C
Thromb Haemost; 1994 Sep; 72(3):438-43. PubMed ID: 7531877
[TBL] [Abstract][Full Text] [Related]
26. Ultra-low dose aprotinin effects on reducing the need for blood transfusion in cardiac surgery.
Parvizi R; Azarfarin R; Hassanzadeh S
Saudi Med J; 2007 Jan; 28(1):49-53. PubMed ID: 17206289
[TBL] [Abstract][Full Text] [Related]
27. Effects of aprotinin dosage on renal function: an analysis of 8,548 cardiac surgical patients treated with different dosages of aprotinin.
Dietrich W; Busley R; Boulesteix AL
Anesthesiology; 2008 Feb; 108(2):189-98. PubMed ID: 18212563
[TBL] [Abstract][Full Text] [Related]
28. Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin.
Llamas P; Cabrera R; Gómez-Arnau J; Fernández MN
Haematologica; 1998 Apr; 83(4):338-46. PubMed ID: 9592984
[TBL] [Abstract][Full Text] [Related]
29. [On the modification of postoperative blood circulation and coagulation changes with the proteinase inhibitor trasylol].
Haberland GL; Matis P; Pauschinger P; Thies HA; Vinazzer H
Med Welt; 1969 May; 22():1270-5. PubMed ID: 5306519
[No Abstract] [Full Text] [Related]
30. Haemostasis in oral surgery--the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system.
Sindet-Pedersen S
Dan Med Bull; 1991 Dec; 38(6):427-43. PubMed ID: 1802633
[TBL] [Abstract][Full Text] [Related]
31. [Retrospective study of the efficacy of aprotinin in heart valve surgery in adults].
Gerometta P; Antona C; Parolari A; Fratto P; Alamanni F; Spirito R; Arena V; Biglioli P
Minerva Cardioangiol; 1995; 43(1-2):47-54. PubMed ID: 7540736
[TBL] [Abstract][Full Text] [Related]
32. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?
Kincaid EH; Ashburn DA; Hoyle JR; Reichert MG; Hammon JW; Kon ND
Ann Thorac Surg; 2005 Oct; 80(4):1388-93; discussion 1393. PubMed ID: 16181876
[TBL] [Abstract][Full Text] [Related]
33. PAI-1 gene: pharmacogenetic association of 4G/4G genotype with bleeding after cardiac surgery--pilot study.
Sirgo G; Morales P; Rello J
Eur J Anaesthesiol; 2009 May; 26(5):404-11. PubMed ID: 19521296
[TBL] [Abstract][Full Text] [Related]
34. [Reduction of blood transfusion need with aprotinin in orthopedic surgery. Spanish Study Group on the Use of Aprotinin in Hip Arthroplasty (GEEEAAC)].
Llau Pitarch JV; Díaz Alvarez A; Polonio Enríquez F; Castro Santamaría M; Ruiz Moyano J; García Enguita MA
Rev Esp Anestesiol Reanim; 2000; 47(7):309-16. PubMed ID: 11002715
[TBL] [Abstract][Full Text] [Related]
35. Biochemistry of serine protease inhibitors and their mechanisms of action: a review.
Wegner J
J Extra Corpor Technol; 2003 Dec; 35(4):326-38. PubMed ID: 14979425
[TBL] [Abstract][Full Text] [Related]
36. Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
Baric D; Biocina B; Unic D; Sutlic Z; Rudez I; Vrca VB; Brkic K; Ivkovic M
Eur J Cardiothorac Surg; 2007 Mar; 31(3):366-71; discussion 371. PubMed ID: 17218108
[TBL] [Abstract][Full Text] [Related]
37. [Aprotinin (Antilysin Spofa)--its effect on decreasing hemorrhage in the postoperative period in hip arthroplasty].
Cvachovec K; Sechovská H; Berousek J; Popelka S; Hladíková M
Acta Chir Orthop Traumatol Cech; 2001; 68(5):311-4. PubMed ID: 11759474
[TBL] [Abstract][Full Text] [Related]
38. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
[TBL] [Abstract][Full Text] [Related]
39. Management of bleeding complications in redo cardiac operations.
Smith CR
Ann Thorac Surg; 1998 Apr; 65(4 Suppl):S2-8; discussion S27-8. PubMed ID: 9563396
[TBL] [Abstract][Full Text] [Related]
40. Perioperative approaches to coagulation defects.
Taylor KM
Ann Thorac Surg; 1993 Nov; 56(5 Suppl):S78-82. PubMed ID: 7694554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
